✦ LIBER ✦

Cost-saving opportunities and angiotensin-II receptor blocker prescribing

✍ Scribed by A. M. Grosso; P. N. Bodalia; R. J. MacAllister; A. D. Hingorani; J. C. Moon; M. A. Scott

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Opportunities for cardiovascular risk re

✍ Matthew R. Weir 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 121 KB

Angiotensin II receptor pharmacology and

✍ Chung, O; Csikós, T; Unger, T 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 132 KB

Angiotensin II and angiotensin II recept

✍ Yi-Jen Chen; Yao-Chang Chen; Ching-Tai Tai; Hung-I Yeh; Cheng-I Lin; Shih-Ann Ch 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 323 KB

Trends in co-prescribing of angiotensin

✍ Wan A. H. Wan Md Adnan; Nur L. Zaharan; Kathleen Bennett; Catherine A. Wall 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

Prescribing angiotensin-converting enzym

✍ PAOLO FERRARI 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

Pemphigus foliaceus induced by an angiot

✍ Y. I. Bae; S. J. Yun; S. C. Lee; G. T. Park; J. B. Lee 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB